Biblio Discovery — Demo Discovery Service

5 results for "Peter Connick"

Showing 1–5 · 0.45 seconds · RSS

  1. Journal Article Full text

    Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review

    Sarah Patrick; Peter Connick

    PLOS ONE, Vol. 14 No. 2 · 2019 · English · PLOS Scopus

    Background: Depression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to a lack of uptake for brief assessment tools and uncertainty about their psychometric properties. The 9-item Patient Health Questionnaire…

  2. Journal Article Full text

    The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis

    Daisy Mollison; Robin Sellar; Mark Bastin et al.

    PLOS ONE, Vol. 12 No. 5 · 2017 · English · PLOS Scopus

    Background: Moderate correlation exists between the imaging quantification of brain white matter lesions and cognitive performance in people with multiple sclerosis (MS). This may reflect the greater importance of other features, including subvisible pathology, or methodological limitations of the…

  3. Journal Article Full text

    Systematic review of prediction models in relapsing remitting multiple sclerosis

    Fraser S. Brown; Stella A. Glasmacher; Patrick K. A. Kearns et al.

    PLOS ONE, Vol. 15 No. 5 · 2020 · English · PLOS Scopus

    The natural history of relapsing remitting multiple sclerosis (RRMS) is variable and prediction of individual prognosis challenging. The inability to reliably predict prognosis at diagnosis has important implications for informed decision making especially in relation to disease modifying…

  4. Journal Article Full text

    Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis

    Hanna M. Vesterinen; Peter Connick; Cadi M. J. Irvine et al.

    PLOS ONE, Vol. 10 No. 4 · 2015 · English · PLOS Scopus

    Objective: To develop and implement an evidence based framework to select, from drugs already licenced, candidate oral neuroprotective drugs to be tested in secondary progressive multiple sclerosis. Design: Systematic review of clinical studies of oral putative neuroprotective therapies in MS and…

  5. Journal Article Full text

    Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis

    Rozanna Meijboom; Elizabeth N. York; Agniete Kampaite et al.

    PLOS ONE, Vol. 18 No. 7 · 2023 · English · PLOS Scopus

    Recurrent neuroinflammation in relapsing-remitting MS (RRMS) is thought to lead to neurodegeneration, resulting in progressive disability. Repeated magnetic resonance imaging (MRI) of the brain provides non-invasive measures of atrophy over time, a key marker of neurodegeneration. This study…